NASDAQ: RVPH - Reviva Pharmaceuticals Holdings, Inc.

Yield per half year: +66.67%
Sector: Healthcare

Reporting Reviva Pharmaceuticals Holdings, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд $
0.0254 0.0267 0.0974 0.0668 0.0436 0.1385
Чистая прибыль, млрд $
-0.0017 -0.000847 -0.0038 -0.0085 -0.0243 -39 260.84 -0.0393
EV, млрд $
0.0327 0.018 0.0131 0.0644 0.098 0.0441
EBIT, млрд $
-0.0011 -0.000377 -0.0024 -0.0101 -0.0243 -0.0236 -0.0243
EBITDA, млрд $
-0.000376 -0.0023 -0.0101 -0.0241 -39 503.64 -0.0241
Баланс стоимость, млрд $
-0.0068 0.0074 0.0287 0.0123 0.0057 0.0057
FCF, млрд $
-0.000218 -0.0037 -0.0107 -0.019 -0.0283 -0.0283
Операционный денежный поток, млрд $
-0.0011 -0.000218 -0.0037 -0.0107 -0.019 -0.0283 -0.0283
Операционная прибыль, млрд $
-0.000377 -0.0024 -0.0101 -0.0243 -39 503.64 -0.0395
Операционные расходы, млрд $
0.000377 0.0024 0.0101 0.0243 39 503.64 0.0395


Balance sheet

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
0 0.0088 0.0297 0.0185 0.0234 0.0234
Short Term Investments $
0.0652
Total Current Assets $
0.000119 0 0.0088 0.0314 0.0189 0.0237 0.0237
Чистые активы, млрд $
0 0 0.0088 0.0314 0.0189 0.0129 0.0189
Активы, млрд $
0 0.0088 0.0314 0.0189 0.0237 0.0237
Short Term Debt $
0.0038
Задолженность, млрд $
0.0068 0.0013 0.0027 0.0066 0.018 0.018
Чистый долг, млрд $
0.0038 -0.0088 -0.0297 -0.0185 -0.0234 -0.0185
Долг, млрд $
0.0038 0.000668
Interest income $
0 0.000105 0.000183 0.000499
Расходы на обслуживание долга $
0.000469 0.0015 0 0.000183 0.000198 0.000183
Чист. проц. доходы, млрд $
0 0.000105 0 0.000183 0.000499 0.000499
Амортизация, млрд $
0 0.000106 0.0016 0.000195
Себестоимость, млрд $
0.000725


Share

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS 0.1385 -0.3056 -1.24 -0.5762 -1.25 -1649739.56 -1.41
Цена акции ао 9.78 10.23 10.55 5.19 4.25 5.15 1.8 1.8
Число акций ао, млн 2.6 2.77 3.06 14.79 19.52 23.8 27.92
FCF/акцию -0.0788 -1.22 -0.7213 -0.9715 -1.19 -1.01


Efficiency

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 24.87 -1224.19 -47.19 -118.72 -435382236.61 -686.53 29.22
ROA, % -65140.92 -86.33 -42.43 -96.72 -184219120.55 -165.65 9.39
ROS, % 0 0 0 0 23.20
ROCE, % 5.53 -32.77 -34.77 -188.66 -372.04 -188.66 35.06
Operation Margin, % 0 0 0 0 27.00
Доходность FCF, % -0.8177 -3.83 -15.98 -43.47 -20.46


Coefficients

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-15.12 -31.55 -25.73 -7.83 -1.79 -3.53 30.88
P/BV
-4.25 3.6 1.49 6.73 21.22 24.9 7.77
P/FCF
-122.3 -26.13 -6.26 -2.3 0 0 0 0 38.30
E/P
-0.0661 -0.0317 -0.0389 -0.1276 -0.5581 -0.2835 0 0 0 0.04
EV/EBITDA
-87.09 -7.73 -1.29 -2.67 0 -1.83 24.22
EV/Ebit
-86.89 -7.39 -1.29 -2.65 -1.81 -1.81 -1.81
EV/S
0 0 0 0 7.59
EV/FCF
-149.9 -4.83 -1.22 -3.4 -3.46 -1.56 -1.56 -1.56 44.10
Debt/EBITDA
-10.01 0 0 0 0 2.24
Netdebt/Ebitda
-10.01 3.76 3.49 0.7681 0 0.7676 0.7676 0.7676 1.14
Debt/Ratio
1448.11 0 0 0 0 0.23
Debt/Equity
-0.5528 0 0 0 0 2.62
Debt/Net Income
-4.45 0 0 0 0 3.25
Бета
-1.03 6.7 7.14 7.14 -1.03
Индекс Альтмана
-2.48 -2.98 -2.98 -2.98 -65.39


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.89


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
10 10